Article

You have full text access to this OnlineOpen article

Course and outcome of hepatitis C

  1. Jay H. Hoofnagle M.D.*

Article first published online: 10 FEB 2006

DOI: 10.1002/hep.1840360704

Issue

Hepatology

Hepatology

Supplement: National Institutes of Health Consensus Development Conference

Volume 36, Issue Supplement 1, pages S21–S29, November 2002

Additional Information

How to Cite

Hoofnagle, J. H. (2002), Course and outcome of hepatitis C. Hepatology, 36: S21–S29. doi: 10.1002/hep.1840360704

Author Information

  1. Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD

*Division of Digestive Diseases and Nutrition. National Institute of Diabetes and Digestive and Kidney Diseases, Bldg. 31 Room 9A27, 31 Center Dr., National Institutes of Health, Bethesda, MD 20892. fax: 301–480–2675

Publication History

  1. Issue published online: 10 FEB 2006
  2. Article first published online: 10 FEB 2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (1085K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jose Ramón Vidal-Castiñeira, Antonio López-Vázquez, Rebeca Alonso-Arias, Marco Antonio Moro-García, Pablo Martinez-Camblor, Santiago Melón, Jesús Prieto, Rosario López-Rodriguez, Paloma Sanz-Cameno, Luis Rodrigo, Rosa Pérez-López, Ramón Pérez-Álvarez, Carlos López-Larrea, A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping, Journal of Hepatology, 2012,

    CrossRef

  2. 2
    T. Karamitros, A. Kakkanas, A. Katsoulidou, V. Sypsa, G. Dalagiorgou, P. Mavromara, A. Hatzakis, Detection of specific antibodies to HCV-ARF/CORE+1 protein in patients treated with pegylated interferon plus ribavirin, Journal of Viral Hepatitis, 2012, 19, 3
    Direct Link:
  3. 3
    Shah Jahan, Usman A. Ashfaq, Saba Khaliq, Baila Samreen, Nadeem Afzal, Dual behavior of HCV Core gene in regulation of apoptosis is important in progression of HCC, Infection, Genetics and Evolution, 2012, 12, 2, 236

    CrossRef

  4. 4
    Wen-Bo WANG, Gang XU, Yan WANG, Qing-Yuan TAO, Hao REN, Zhong-Tian QI, Effect of Hepatitis C F Protein and Core Secondary Structure on Viral Replication and Infection*, PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2012, 39, 2, 142

    CrossRef

  5. 5
    Carol S. North, Barry A. Hong, Thomas Kerr, Hepatitis C and substance use, Current Opinion in Psychiatry, 2012, 25, 3, 206

    CrossRef

  6. 6
    Nicola F. Fletcher, Garrick K. Wilson, Jacinta Murray, Ke Hu, Andrew Lewis, Gary M. Reynolds, Zania Stamataki, Luke W. Meredith, Ian A. Rowe, Guangxiang Luo, Miguel A. Lopez–Ramirez, Thomas F. Baumert, Babette Weksler, Pierre–Olivier Couraud, Kwang Sik Kim, Ignacio A. Romero, Catherine Jopling, Susan Morgello, Peter Balfe, Jane A. McKeating, Hepatitis C Virus Infects the Endothelial Cells of the Blood-Brain Barrier, Gastroenterology, 2012, 142, 3, 634

    CrossRef

  7. 7
    Maemu P. Gededzha, Selokela G. Selabe, Thanda Kyaw, J. Nare Rakgole, Jason T. Blackard, M. Jeffery Mphahlele, Introduction of new subtypes and variants of hepatitis C virus genotype 4 in South Africa, Journal of Medical Virology, 2012, 84, 4
    Direct Link:
  8. 8
    Bogna J. ÅšwiÄ…tek, Is interleukin-10 gene polymorphism a predictive marker in HCV infection?, Cytokine & Growth Factor Reviews, 2012, 23, 1-2, 47

    CrossRef

  9. 9
    Safieh Amini, Seyed Moayed Alavian, Ehsan Mostafavi, Rouhollah Vahabpour, Golnaz Bahramali, Mohammad Reza Aghasadeghi, Arash Arashkia, Presence of plus-strand HCV RNA in serum and PBMCs as an indicator for relapse and resistance to IFN therapy in patients infected by HCV, Future Virology, 2012, 7, 3, 323

    CrossRef

  10. 10
    Yun Jung Kim, Byoung Kuk Jang, Eun Soo Kim, Kyung Sik Park, Kwang Bum Cho, Woo Jin Chung, Jae Seok Hwang, Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients, The Korean Journal of Hepatology, 2012, 18, 1, 41

    CrossRef

  11. 11
    Hiromitsu Kumada, Joji Toyota, Takeshi Okanoue, Kazuaki Chayama, Hirohito Tsubouchi, Norio Hayashi, Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan, Journal of Hepatology, 2012, 56, 1, 78

    CrossRef

  12. 12
    G. Esmat, M. El Raziky, M. El Kassas, M. Hassany, M.E. Gamil, The future for the treatment of genotype 4 chronic hepatitis C, Liver International, 2012, 32,
    Direct Link:
  13. 13
    Christina Schlecker, Alfred Ultsch, Gerd Geisslinger, Jörn Lötsch, The pharmacogenetic background of hepatitis C treatment, Mutation Research/Reviews in Mutation Research, 2012,

    CrossRef

  14. 14
    B. Soldevila, N. Alonso, M. J. Martínez-Arconada, R. M. Morillas, R. Planas, A. M. Sanmartí, E. M. Martínez-Cáceres, A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4+CD25+CD127low/−FoxP3+ T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment, Journal of Viral Hepatitis, 2011, 18, 6
    Direct Link:
  15. 15
    Federica Bozzano, Antonino Picciotto, Paola Costa, Francesco Marras, Valentina Fazio, Ivan Hirsch, Daniel Olive, Lorenzo Moretta, Andrea De Maria, Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment, European Journal of Immunology, 2011, 41, 10
    Direct Link:
  16. 16
    Po-Yuan Ke, Steve S.-L. Chen, Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro, Journal of Clinical Investigation, 2011, 121, 1, 37

    CrossRef

  17. 17
    Heidi Barth, Jolanta Rybczynska, Romuald Patient, Youkyung Choi, Ronda K. Sapp, Thomas F. Baumert, Kris Krawczynski, T. Jake Liang, Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees, Hepatology, 2011, 54, 4
    Direct Link:
  18. 18
    Yasushi Inoue, Hideki Aizaki, Hiromichi Hara, Mami Matsuda, Tomomi Ando, Tetsu Shimoji, Kyoko Murakami, Takahiro Masaki, Ikuo Shoji, Sakae Homma, Yoshiharu Matsuura, Tatsuo Miyamura, Takaji Wakita, Tetsuro Suzuki, Chaperonin TRiC/CCT participates in replication of hepatitis C virus genome via interaction with the viral NS5B protein, Virology, 2011, 410, 1, 38

    CrossRef

  19. 19
    Geilan A. Mahmoud, Hania S. Zayed, Mai M. Sherif, Mervat M. Mostafa, Characteristics of rheumatoid arthritis patients with concomitant hepatitis C virus infection, The Egyptian Rheumatologist, 2011, 33, 3, 139

    CrossRef

  20. 20
    Basmattee Boodram, Ronald C. Hershow, Scott J. Cotler, Lawrence J. Ouellet, Chronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug users, Drug and Alcohol Dependence, 2011, 119, 3, 166

    CrossRef

  21. 21
    Louise Nygaard Clausen, Nina Weis, Kristian Schønning, Mogens Fenger, Henrik Krarup, Jens Bukh, Thomas Benfield, Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort, Scandinavian Journal of Infectious Diseases, 2011, 43, 10, 798

    CrossRef

  22. 22
    E. S. Machlin, P. Sarnow, S. M. Sagan, Cozzarelli Prize Winner: From the Cover: Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex, Proceedings of the National Academy of Sciences, 2011, 108, 8, 3193

    CrossRef

  23. 23
    Bo Zhang, Lan Zheng, Yuwen Huang, Qin Mo, Xun Wang, Kaicheng Qian, Detection of Nucleic Acid Lesions During Photochemical Inactivation of RNA Viruses by Treatment with Methylene Blue and Light Using Real-time PCR, Photochemistry and Photobiology, 2011, 87, 2
    Direct Link:
  24. 24
    Varun Garg, Rolf van Heeswijk, Jee Eun Lee, Katia Alves, Priya Nadkarni, Xia Luo, Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus, Hepatology, 2011, 54, 1
    Direct Link:
  25. 25
    Peng-Jian Weng, Yan-Min Fu, Shi-Xiong Ding, Dan-Ping Xu, Aifen Lin, Wei-Hua Yan, Elevation of plasma soluble human leukocyte antigen–G in patients with chronic hepatitis C virus infection, Human Immunology, 2011, 72, 5, 406

    CrossRef

  26. 26
    Sanaa M. Kamal, Amany Ahmed, Sara Mahmoud, Leila Nabegh, Iman El Gohary, Isi Obadan, Tamer Hafez, Dahlia Ghoraba, Ahmed A. Aziz, Mona Metaoei, Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis, Liver International, 2011, 31, 3
    Direct Link:
  27. 27
    B. Boodram, R. C. Hershow, D. Klinzman, J. T. Stapleton, GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection, Journal of Viral Hepatitis, 2011, 18, 4
    Direct Link:
  28. 28
    Kate Frazer, Michele Glacken, Barbara Coughlan, Anthony Staines, Leslie Daly, Hepatitis C virus infection in primary care: survey of registered nurses’ knowledge and access to information, Journal of Advanced Nursing, 2011, 67, 2
    Direct Link:
  29. 29
    Saba Khaliq, Shah Jahan, Sajida Hassan, Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target, Liver International, 2011, 31, 5
    Direct Link:
  30. 30
    R. K. Gieseler, G. Marquitan, M. Schlattjan, J.-P. Sowa, L. P. Bechmann, J. Timm, M. Roggendorf, G. Gerken, S. L. Friedman, A. Canbay, Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C, Journal of Viral Hepatitis, 2011, 18, 11
    Direct Link:
  31. 31
    Haji Akbar, Muhammad Idrees, Sadia Butt, Zunaira Awan, Muhammd Farooq Sabar, Irshad ur Rehaman, Abrar Hussain, Sana Saleem, High baseline interleukine-8 level is an Independent risk factor for the achievement of sustained virological response in chronic HCV patients, Infection, Genetics and Evolution, 2011, 11, 6, 1301

    CrossRef

  32. 32
    G. Dalagiorgou, N. Vassilaki, P. Foka, A. Boumlic, A. Kakkanas, E. Kochlios, S. Khalili, E. Aslanoglou, S. Veletza, G. Orfanoudakis, D. Vassilopoulos, S. J. Hadziyannis, J. Koskinas, P. Mavromara, High levels of HCV core+1 antibodies in HCV patients with hepatocellular carcinoma, Journal of General Virology, 2011, 92, 6, 1343

    CrossRef

  33. 33
    Amir Moghaddam, Espen Melum, Nils Reinton, Helmer Ring-Larsen, Hans Verbaan, Kristian Bjøro, Olav Dalgard, IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection, Hepatology, 2011, 53, 3
    Direct Link:
  34. 34
    Sonya A MacParland, Bahareh Vali, Mario A Ostrowski, Immunopathogenesis of HIV/hepatitis C virus coinfection, Future Virology, 2011, 6, 9, 1115

    CrossRef

  35. 35
    Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Hitomi Sezaki, Miharu Hirakawa, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saito, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Kazuaki Chayama, Naoyuki Kamatani, Yusuke Nakamura, Yuzo Miyakawa, Hiromitsu Kumada, Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir, Hepatology, 2011, 53, 2
    Direct Link:
  36. 36
    Heidi Barth, Insights into the role of interferon lambda in hepatitis C virus infection, Journal of Hepatology, 2011, 54, 5, 844

    CrossRef

  37. 37
    L. N. Clausen, N. Weis, K. Astvad, K. Schønning, M. Fenger, H. Krarup, J. Bukh, T. Benfield, Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort, Journal of Viral Hepatitis, 2011, 18, 4
    Direct Link:
  38. 38
    Alexander R. Moschen, Teresa Fritz, Andrew D. Clouston, Ilka Rebhan, Oliver Bauhofer, Helen D. Barrie, Elizabeth E. Powell, Soo-Hyun Kim, Charles A. Dinarello, Ralf Bartenschlager, Julie R. Jonsson, Herbert Tilg, Interleukin-32: A new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis, Hepatology, 2011, 53, 6
    Direct Link:
  39. 39
    Eun Jung Kang, Dong Kyun Kim, Seong Ran Jeon, Hyun Sook Choi, Soung Won Jeong, Jae Young Jang, Joon Seong Lee, Soo Taek Uh, Interstitial Pneumonitis in a Patient with Chronic Hepatitis C and Chronic Renal Failure on Interferon Therapy, The Korean Journal of Gastroenterology, 2011, 58, 1, 47

    CrossRef

  40. 40
    Bahaeldin K. Elamin, Elisa Callegari, Laura Gramantieri, Silvia Sabbioni, Massimo Negrini, MicroRNA response to environmental mutagens in liver, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2011, 717, 1-2, 67

    CrossRef

  41. 41
    Gang Long, Marie–Sophie Hiet, Marc P. Windisch, Ji–Young Lee, Volker Lohmann, Ralf Bartenschlager, Mouse Hepatic Cells Support Assembly of Infectious Hepatitis C Virus Particles, Gastroenterology, 2011, 141, 3, 1057

    CrossRef

  42. 42
    Y. Fu, Y. Wang, W. Xia, O. G. Pybus, W. Qin, L. Lu, K. Nelson, New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors, Journal of Viral Hepatitis, 2011, 18, 1
    Direct Link:
  43. 43
    Usman Ali Ashfaq, Muhammad Ansar, Muhammad Sarwar, Tariq Javed, Sidra Rehman, Sheikh Riazuddin, Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA, Virology Journal, 2011, 8, 1, 112

    CrossRef

  44. 44
    Mohammed T.A. Salim, Hiroshi Aoyama, Kazuyuki Sugita, Kouichi Watashi, Takaji Wakita, Takayuki Hamasaki, Mika Okamoto, Yasuo Urata, Yuichi Hashimoto, Masanori Baba, Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives, Biochemical and Biophysical Research Communications, 2011, 415, 4, 714

    CrossRef

  45. 45
    M. Cornberg, M.P. Manns, Prävention der Virushepatitis A bis E, Der Internist, 2011, 52, 3, 250

    CrossRef

  46. 46
    K. S. Louie, J. M. Micallef, J. M. Pimenta, U. M. Forssen, Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review, Journal of Viral Hepatitis, 2011, 18, 1
    Direct Link:
  47. 47
    Debasis Das, Jian Hong, Shu-Hui Chen, Guangyi Wang, Leonid Beigelman, Scott D. Seiwert, Brad O. Buckman, Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors, Bioorganic & Medicinal Chemistry, 2011, 19, 16, 4690

    CrossRef

  48. 48
    Christopher J. Horras, Cheri L. Lamb, Kristen A. Mitchell, Regulation of hepatocyte fate by interferon-γ, Cytokine & Growth Factor Reviews, 2011, 22, 1, 35

    CrossRef

  49. 49
    Marina M. May, Heike Lorengel, Joerg Kreuter, Holger Zimmermann, Helga Ruebsamen-Schaeff, Andreas Urban, RNA-dependent RNA polymerases from different hepatitis C virus genotypes reveal distinct biochemical properties and drug susceptibilities, Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics, 2011, 1814, 10, 1325

    CrossRef

  50. 50
    Ana Montero, Pablo Gastaminza, Mansun Law, Guofeng Cheng, Francis V. Chisari, M. Reza Ghadiri, Self-Assembling Peptide Nanotubes with Antiviral Activity against Hepatitis C Virus, Chemistry & Biology, 2011, 18, 11, 1453

    CrossRef

  51. 51
    Saba Khaliq, Shah Jahan, Asim Pervaiz, Sequence variability of HCV Core region: Important predictors of HCV induced pathogenesis and viral production, Infection, Genetics and Evolution, 2011, 11, 3, 543

    CrossRef

  52. 52
    Julien Guergnon, Ioannis Theodorou, What did we learn on hostʼs genetics by studying large cohorts of HIV-1-infected patients in the genome-wide association era?, Current Opinion in HIV and AIDS, 2011, 6, 4, 290

    CrossRef

  53. 53
    Nihon Toseki Igakkai Zasshi, 2011, 44, 6, 487

    CrossRef

  54. 54
    Omar Dessouki, Yasuyuki Kamiya, Hiroyasu Nagahama, Motohiko Tanaka, Shinya Suzu, Yutaka Sasaki, Seiji Okada, Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment, Biochemical and Biophysical Research Communications, 2010, 393, 2, 331

    CrossRef

  55. 55
    Fernando González-Candelas, F Xavier López-Labrador, Clinical relevance of genetic heterogeneity in HCV, Future Virology, 2010, 5, 1, 33

    CrossRef

  56. 56
    Charalabos-Markos Dintsios, Alexander Haverkamp, Johannes Wiegand, Tilman Gerlach, Heiner Wedemeyer, Gerd Pape, Michael Peter Manns, Christian Krauth, Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany, European Journal of Gastroenterology & Hepatology, 2010, 22, 3, 278

    CrossRef

  57. 57
    Swati DebRoy, Christopher Kribs-Zaleta, Anuj Mubayi, Gloriell M. Cardona-Meléndez, Liana Medina-Rios, MinJun Kang, Edgar Diaz, Evaluating treatment of hepatitis C for hemolytic anemia management, Mathematical Biosciences, 2010, 225, 2, 141

    CrossRef

  58. 58
    Masaaki Satoh, Makoto Saito, Kohsuke Tanaka, Sumako Iwanaga, Salem Nagla Elwy Salem Ali, Takahiro Seki, Seiji Okada, Michinori Kohara, Shinji Harada, Chieko Kai, Kyoko Tsukiyama-Kohara, Evaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD/Scid/Jak3null mouse, Comparative Immunology, Microbiology and Infectious Diseases, 2010, 33, 6, e81

    CrossRef

  59. 59
    P. Vaghefi, E. Marchadier, E. Dussaix, A.-M. Roque-Afonso, Génotypage du virus de l’hépatite C : comparaison du test Abbott RealTime HCV Genotype II au séquençage de la région NS5B, Pathologie Biologie, 2010, 58, 2, 175

    CrossRef

  60. 60
    Andri Rauch, Zoltán Kutalik, Patrick Descombes, Tao Cai, Julia Di Iulio, Tobias Mueller, Murielle Bochud, Manuel Battegay, Enos Bernasconi, Jan Borovicka, Sara Colombo, Andreas Cerny, Jean–François Dufour, Hansjakob Furrer, Huldrych F. Günthard, Markus Heim, Bernard Hirschel, Raffaele Malinverni, Darius Moradpour, Beat Müllhaupt, Andrea Witteck, Jacques S. Beckmann, Thomas Berg, Sven Bergmann, Francesco Negro, Amalio Telenti, Pierre–Yves Bochud, Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study, Gastroenterology, 2010, 138, 4, 1338

    CrossRef

  61. 61
    Srunthron Akkarathamrongsin, Kesmanee Praianantathavorn, Nisachol Hacharoen, Apiradee Theamboonlers, Pisit Tangkijvanich, Yasuhito Tanaka, Masashi Mizokami, Yong Poovorawan, Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand, Journal of Medical Virology, 2010, 82, 2
    Direct Link:
  62. 62
    A. K. P. Lim, N. Patel, R. J. Eckersley, J. F. L. Cobbold, M. M. E. Crossey, D. O. Cosgrove, R. D. Goldin, H. C. Thomas, S. D. Taylor-Robinson, Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis C, Journal of Viral Hepatitis, 2010, 17, 11
    Direct Link:
  63. 63
    Nicola F. Fletcher, Jian Ping Yang, Michelle J. Farquhar, Ke Hu, Christopher Davis, Qiuchen He, Kimberly Dowd, Stuart C. Ray, Sophie E. Krieger, Johan Neyts, Thomas F. Baumert, Peter Balfe, Jane A. McKeating, Flossie Wong–Staal, Hepatitis C Virus Infection of Neuroepithelioma Cell Lines, Gastroenterology, 2010, 139, 4, 1365

    CrossRef

  64. 64
    Maria Paola Simula, Valli De Re, Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: A focus on recent advances in proteomics, PROTEOMICS - Clinical Applications, 2010, 4, 10-11
    Direct Link:
  65. 65
    Srunthron Akkarathamrongsin, Masaya Sugiyama, Kentaro Matsuura, Fuat Kurbanov, Yong Poovorawan, Yasuhito Tanaka, Masashi Mizokami, High sensitivity assay using serum sample for IL28B genotyping to predict treatment response in chronic hepatitis C patients, Hepatology Research, 2010, 40, 10
    Direct Link:
  66. 66
    Sandy Pelletier, Christian Drouin, Nathalie Bédard, Salim I. Khakoo, Julie Bruneau, Naglaa H. Shoukry, Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses, Journal of Hepatology, 2010, 53, 5, 805

    CrossRef

  67. 67
    Kerstin A. Stegmann, Niklas K. Björkström, Heike Veber, Sandra Ciesek, Peggy Riese, Johannes Wiegand, Johannes Hadem, Pothakamuri V. Suneetha, Jerzy Jaroszewicz, Chun Wang, Verena Schlaphoff, Paraskevi Fytili, Markus Cornberg, Michael P. Manns, Robert Geffers, Thomas Pietschmann, Carlos A. Guzmán, Hans–Gustaf Ljunggren, Heiner Wedemeyer, Interferon-α–Induced TRAIL on Natural Killer Cells Is Associated With Control of Hepatitis C Virus Infection, Gastroenterology, 2010, 138, 5, 1885

    CrossRef

  68. 68
    Philippe Halfon, Sophie Pérusat, Marc Bourlière, Jean-Pierre Bronowicki, Pascale Trimoulet, Yves Benhamou, Vincent Leroy, Patrick Marcellin, Juliette Foucher, Guillaume Penaranda, Geneviève Chêne, Patrice Couzigou, Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy*), Journal of Medical Virology, 2010, 82, 12
    Direct Link:
  69. 69
    Brett D. Lindenbach, New Cell Culture Models of Hepatitis C Virus Entry, Replication, and Virus Production, Gastroenterology, 2010, 139, 4, 1090

    CrossRef

  70. 70
    T. Watanabe, A. Bertoletti, T. A. Tanoto, PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection, Journal of Viral Hepatitis, 2010, 17, 7
    Direct Link:
  71. 71
    Scott Grier, Nayna Patel, Yu-Ting Kuo, David O. Cosgrove, Robert C. Goldin, Howard C. Thomas, Simon D. Taylor-Robinson, Adrian K.P. Lim, Perihepatic lymph nodes as markers of disease response in patients with hepatitis C-related liver disease: a prospective clinical evaluation, European Journal of Gastroenterology & Hepatology, 2010, 22, 3, 257

    CrossRef

  72. 72
    Kisun Ryu, Kyun-Hwan Kim, Seong-Yeon Yoo, Eun-Young Lee, Keo-Heun Lim, Mi-Kyung Min, Hajeong Kim, Seong Il Choi, Baik L. Seong, Production and characterization of active hepatitis C virus RNA-dependent RNA polymerase, Protein Expression and Purification, 2010, 71, 2, 147

    CrossRef

  73. 73
    Marie-Josée Massariol, Songping Zhao, Martin Marquis, Diane Thibeault, Peter W. White, Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3–NS4A proteins, Biochemical and Biophysical Research Communications, 2010, 391, 1, 692

    CrossRef

  74. 74
    Abdelhakim Ahmed–Belkacem, Nazim Ahnou, Laetitia Barbotte, Czeslaw Wychowski, Coralie Pallier, Rozenn Brillet, Ralf–Torsten Pohl, Jean–Michel Pawlotsky, Silibinin and Related Compounds Are Direct Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase, Gastroenterology, 2010, 138, 3, 1112

    CrossRef

  75. 75
    Madiha Mohamed El-Attar, Mohamed Abdel-Hamid Ahmed, Magda Shehata Hasan, Mohamed Ahmed Aly, Ahmed Medhat Nasr, Spontaneous viral clearance of chronic HCV infection in Upper Egypt: A community-based study with a 10year follow-up, Arab Journal of Gastroenterology, 2010, 11, 4, 197

    CrossRef

  76. 76
    Bokhui Lee, Kyung Bo Kim, Sangtaek Oh, Joon Sig Choi, Jong-Sang Park, Dal-Hee Min, Dong-Eun Kim, Suppression of Hepatitis C Virus Genome Replication in Cells with RNA-Cleaving DNA Enzymes and Short-Hairpin RNA, Oligonucleotides, 2010, 20, 6, 285

    CrossRef

  77. 77
    E. G. GIANNINI, M. BASSO, V. SAVARINO, A. PICCIOTTO, Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients, Alimentary Pharmacology & Therapeutics, 2010, 31, 4
    Direct Link:
  78. 78
    Iou-Jiun Kang, Li-Wen Wang, Teng-Kuang Yeh, Chung-Chi Lee, Yen-Chun Lee, Sheng-Ju Hsu, Yen-Shian Wu, Jing-Chyi Wang, Yu-Sheng Chao, Andrew Yueh, Jyh-Haur Chern, Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors, Bioorganic & Medicinal Chemistry, 2010, 18, 17, 6414

    CrossRef

  79. 79
    Céline Beauvillain, Francesca Meloni, Jean-Claude Sirard, Simon Blanchard, Ulrich Jarry, Mari Scotet, Giovanni Magistrelli, Yves Delneste, Vincenzo Barnaba, Pascale Jeannin, The scavenger receptors SRA-1 and SREC-I cooperate with TLR2 in the recognition of the hepatitis C virus non-structural protein 3 by dendritic cells, Journal of Hepatology, 2010, 52, 5, 644

    CrossRef

  80. 80
    Yongshui Fu, Wenjie Xia, Yizhong Wang, Linwei Tian, Oliver G. Pybus, Ling Lu, Kenrad Nelson, The seroprevalence of hepatitis C virus (HCV) among 559,890 first-time volunteer blood donors in China reflects regional heterogeneity in HCV prevalence and changes in blood donor recruitment models, Transfusion, 2010, 50, 7
    Direct Link:
  81. 81
    Christopher Davis, Helen J. Harris, Jane A. McKeating, Current Topics in Membranes Volume 65, 2010,

    CrossRef

  82. 82
    Kevin X. Chen, F. George Njoroge, Progress in Medicinal Chemistry Volume 49, 2010,

    CrossRef

  83. 83
    Michaela Iro, Jeroen Witteveldt, Allan G.N. Angus, Ilka Woerz, Artur Kaul, Ralf Bartenschlager, Arvind H. Patel, A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication, Antiviral Research, 2009, 83, 2, 148

    CrossRef

  84. 84
    R. Scott Thurston, Acute hepatitis C virus and cardiac surgeons, The Journal of Thoracic and Cardiovascular Surgery, 2009, 137, 3, 519

    CrossRef

  85. 85
    Yannick Simonin, Olivier Disson, Hervé Lerat, Etienne Antoine, Fabien Binamé, Arielle R. Rosenberg, Solange Desagher, Patrice Lassus, Paulette Bioulac-Sage, Urszula Hibner, Calpain activation by hepatitis C virus proteins inhibits the extrinsic apoptotic signaling pathway, Hepatology, 2009, 50, 5
    Direct Link:
  86. 86
    Tobias Hitziger, Michael Schmidt, Volkmar Schottstedt, Holger Hennig, Alexandra Schumann, Stefan Ross, Mengji Lu, Erhard Seifried, Michael Roggendorf, Cellular immune response to hepatitis C virus (HCV) in nonviremic blood donors with indeterminate anti-HCV reactivity, Transfusion, 2009, 49, 7
    Direct Link:
  87. 87
    Silvia Ferri, Luigi Muratori, Chiara Quarneti, Paolo Muratori, Rita Menichella, Georgios Pappas, Alessandro Granito, Giorgio Ballardini, Francesco B. Bianchi, Marco Lenzi, Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C, Journal of Hepatology, 2009, 50, 6, 1093

    CrossRef

  88. 88
    Ulrike Mihm, Oliver Ackermann, Christoph Welsch, Eva Herrmann, Wolf Peter Hofmann, Natalia Grigorian, Martin Walter Welker, Thomas Lengauer, Stefan Zeuzem, Christoph Sarrazin, Clinical relevance of the 2′–5′-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis C, Journal of Hepatology, 2009, 50, 1, 49

    CrossRef

  89. 89
    Qingxia Han, Chunlian Xu, Chunchen Wu, Wenbo Zhu, Rongge Yang, Xinwen Chen, Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus, Virus Research, 2009, 145, 1, 63

    CrossRef

  90. 90
    Iou-Jiun Kang, Li-Wen Wang, Sheng-Ju Hsu, Chung-Chi Lee, Yen-Chun Lee, Yen-Shian Wu, Andrew Yueh, Jing-Chyi Wang, Tsu-An Hsu, Yu-Sheng Chao, Jyh-Haur Chern, Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors, Bioorganic & Medicinal Chemistry Letters, 2009, 19, 21, 6063

    CrossRef

  91. 91
    Iou-Jiun Kang, Li-Wen Wang, Sheng-Ju Hsu, Chung-Chi Lee, Yen-Chun Lee, Yen-Shian Wu, Tsu-An Hsu, Andrew Yueh, Yu-Sheng Chao, Jyh-Haur Chern, Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors, Bioorganic & Medicinal Chemistry Letters, 2009, 19, 15, 4134

    CrossRef

  92. 92
    Iou-Jiun Kang, Li-Wen Wang, Chung-Chi Lee, Yen-Chun Lee, Yu-Sheng Chao, Tsu-An Hsu, Jyh-Haur Chern, Design, synthesis, and anti-HCV activity of thiourea compounds, Bioorganic & Medicinal Chemistry Letters, 2009, 19, 7, 1950

    CrossRef

  93. 93
    Xiaoping Qi, Andrew Bae, Shan Liu, Huiling Yang, Siu-Chi Sun, Jeanette Harris, William Delaney, Michael Miller, Hongmei Mo, Development of a replicon-based phenotypic assay for assessing the drug susceptibilities of HCV NS3 protease genes from clinical isolates, Antiviral Research, 2009, 81, 2, 166

    CrossRef

  94. 94
    Daniel P Webster, Paul Klenerman, Jane Collier, Katie JM Jeffery, Development of novel treatments for hepatitis C, The Lancet Infectious Diseases, 2009, 9, 2, 108

    CrossRef

  95. 95
    Marc G. Ghany, Doris B. Strader, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009, 49, 4
    Direct Link:
  96. 96
    C. Li, L. Lu, X. Zhang, D. Murphy, Entire genome sequences of two new HCV subtypes, 6r and 6s, and characterization of unique HVR1 variation patterns within genotype 6, Journal of Viral Hepatitis, 2009, 16, 6
    Direct Link:
  97. 97
    Hui-Ying Rao, Fu-Rong Ren, Wen-Li Guan, Michel Houde, Shao-Cai Du, Chang-Li Liu, Xiao-Yan Gong, Lai Wei, Evaluation of the performance of the EIAgen HCV test for detection of hepatitis C virus infection, Journal of Virological Methods, 2009, 162, 1-2, 203

    CrossRef

  98. 98
    Sarah Welbourn, Arnim Pause, HCV NS2/3 protease: a future antiviral drug target?, Future Virology, 2009, 4, 5, 463

    CrossRef

  99. 99
    Urtzi Garaigorta, Francis V. Chisari, Hepatitis C Virus Blocks Interferon Effector Function by Inducing Protein Kinase R Phosphorylation, Cell Host & Microbe, 2009, 6, 6, 513

    CrossRef

  100. 100
    Sara Raimondi, Savino Bruno, Mario U. Mondelli, Patrick Maisonneuve, Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis, Journal of Hepatology, 2009, 50, 6, 1142

    CrossRef

  101. 101
    I. Woerz, V. Lohmann, R. Bartenschlager, Hepatitis C virus replicons: dinosaurs still in business?, Journal of Viral Hepatitis, 2009, 16, 1
    Direct Link:
  102. 102
    Andri Rauch, Silvana Gaudieri, Chloe Thio, Pierre-Yves Bochud, Host genetic determinants of spontaneous hepatitis C clearance, Pharmacogenomics, 2009, 10, 11, 1819

    CrossRef

  103. 103
    Hirofumi Uto, Sherri O. Stuver, Katsuhiro Hayashi, Kotaro Kumagai, Fumisato Sasaki, Shuji Kanmura, Masatsugu Numata, Akihiro Moriuchi, Susumu Hasegawa, Makoto Oketani, Akio Ido, Kazunori Kusumoto, Satoru Hasuike, Kenji Nagata, Michinori Kohara, Hirohito Tsubouchi, Increased rate of death related to presence of viremia among hepatitis C virus antibody–positive subjects in a community-based cohort study, Hepatology, 2009, 50, 2
    Direct Link:
  104. 104
    Ivan Gentile, Chiara Viola, Luigi Paesano, Marcello D'Onofrio, Elio D'Agostino, Raimondo Cerini, Francesco Borrelli, Marcello Piazza, Guglielmo Borgia, Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial, Journal of Clinical Apheresis, 2009, 24, 5
    Direct Link:
  105. 105
    Daniel Sauter, Kiyoshi Himmelsbach, Malte Kriegs, Monica Carvajal Yepes, Eberhard Hildt, Localization determines function: N-terminally truncated NS5A fragments accumulate in the nucleus and impair HCV replication, Journal of Hepatology, 2009, 50, 5, 861

    CrossRef

  106. 106
    Emilio Palumbo, Peg-Interferon in Acute and Chronic Hepatitis C: A Review, American Journal of Therapeutics, 2009, 16, 6, 573

    CrossRef

  107. 107
    Hesham El Makhzangy, Gamal Esmat, Mohamed Said, Maissa ElRaziky, Soheir Shouman, Rasha Refai, Claire Rekacewicz, Rita Raafat Gad, Nicolas Vignier, Mohamed Abdel-Hamid, Khaled Zalata, Pierre Bedossa, Stanislas Pol, Arnaud Fontanet, Mostafa K. Mohamed, Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4, Journal of Medical Virology, 2009, 81, 9
    Direct Link:
  108. 108
    Mohammad Irshad, Retracted: Genetic diversity in hepatitis C virus (HCV): A brief review, Reviews in Medical Virology, 2009, 19, 3
    Direct Link:
  109. 109
    Feng He, Sangeeta B. Joshi, Fons Bosman, Marijke Verhaeghe, C. Russell Middaugh, Structural stability of hepatitis C virus envelope glycoprotein E1: Effect of pH and dissociative detergents, Journal of Pharmaceutical Sciences, 2009, 98, 9
    Direct Link:
  110. 110
    Niki Vassilaki, Penelope Mavromara, The HCV ARFP/F/core+1 protein: Production and functional analysis of an unconventional viral product, IUBMB Life, 2009, 61, 7
    Direct Link:
  111. 111
    P. Gastaminza, C. Whitten-Bauer, F. V. Chisari, Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection, Proceedings of the National Academy of Sciences, 2009, 107, 1, 291

    CrossRef

  112. 112
    L. Jaffrelo, S. Chabas, S. Reigadas, A. Pflieger, C. Wychowski, J. Rumi, M. Ventura, J.-J. Toulme, C. Staedel, A functional selection of viral genetic elements in cultured cells to identify hepatitis C virus RNA translation inhibitors, Nucleic Acids Research, 2008, 36, 15, e95

    CrossRef

  113. 113
    G. Cheng, A. Montero, P. Gastaminza, C. Whitten-Bauer, S. F. Wieland, M. Isogawa, B. Fredericksen, S. Selvarajah, P. A. Gallay, M. R. Ghadiri, F. V. Chisari, A virocidal amphipathic  -helical peptide that inhibits hepatitis C virus infection in vitro, Proceedings of the National Academy of Sciences, 2008, 105, 8, 3088

    CrossRef

  114. 114
    Andrea Normann, Selim Badur, Derya Önel, Ayse Kilic, Müjgan Sidal, Bernard Larouzé, Veronique Massari, Julia Müller, Bertram Flehmig, Acute hepatitis A virus infection in Turkey, Journal of Medical Virology, 2008, 80, 5
    Direct Link:
  115. 115
    B. Y. Lan, G. M. Landry, V. O. Tan, A. Bostrom, S. Feng, Ascites in Hepatitis C Liver Transplant Recipients Frequently Occurs in the Absence of Advanced Fibrosis, American Journal of Transplantation, 2008, 8, 2
    Direct Link:
  116. 116
    Radsamee Sermasathanasawadi, Naoya Kato, Ryosuke Muroyama, Narayan Dharel, Run-Xuan Shao, Jin-Hai Chang, Chang-Zheng Li, Takao Kawabe, Masao Omata, Association of interferon regulatory factor -7 gene polymorphism with liver cirrhosis in chronic hepatitis C patients, Liver International, 2008, 28, 6
    Direct Link:
  117. 117
    F. Schramm, R. Moenne-Loccoz, S. Fafi-Kremer, E. Soulier, C. Royer, T. Weitten, N. Brignon, B. Ellero, M.-L. Woehl-Jaegle, C. Meyer, P. Wolf, M. Doffoel, T.-F. Baumert, J.-P. Gut, F. Stoll-Keller, E. Schvoerer, Étude du leucotropisme du virus de l’hépatite C par analyse des quasi-espèces virales dans le contexte de la transplantation hépatique, Pathologie Biologie, 2008, 56, 7-8, 487

    CrossRef

  118. 118
    Xueshan Xia, Wenhua Zhao, Kok Keng Tee, Yue Feng, Yutaka Takebe, Qihan Li, Oliver G. Pybus, Ling Lu, Complete genome sequencing and phylogenetic analysis of HCV isolates from China reveals a new subtype, designated 6u, Journal of Medical Virology, 2008, 80, 10
    Direct Link:
  119. 119
    E. MASSAD, F. A. B. COUTINHO, E. CHAIB, M. N. BURATTINI, Cost-effectiveness analysis of a hypothetical hepatitis C vaccine compared to antiviral therapy, Epidemiology and Infection, 2008, 137, 02, 241

    CrossRef

  120. 120
    David M. Novick, Mary Jeanne Kreek, Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients, Addiction, 2008, 103, 6
    Direct Link:
  121. 121
    N. Vassilaki, K. I. Kalliampakou, P. Mavromara, Differences in the expression of the hepatitis C virus core+1 open reading frame between a nuclear and a cytoplasmic expression system, Journal of General Virology, 2008, 89, 1, 222

    CrossRef

  122. 122
    Imre Altuglu, Ilknur Soyler, Tijen Ozacar, Selda Erensoy, Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey, International Journal of Infectious Diseases, 2008, 12, 3, 239

    CrossRef

  123. 123
    A. Ramunni, G. Lauletta, P. Brescia, M.T. Saliani, M. Montrone, M. Chironna, D. Sansonno, F. Dammacco, P. Coratelli, Double-filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinemia, Journal of Clinical Apheresis, 2008, 23, 3
    Direct Link:
  124. 124
    Niki Vassilaki, Haralabia Boleti, Penelope Mavromara, Expression studies of the HCV-1a core+1 open reading frame in mammalian cells, Virus Research, 2008, 133, 2, 123

    CrossRef

  125. 125
    Shu-Chuan Chang, Wang-Sheng Ko, Shun-Sheng Wu, Cheng-Yuan Peng, Sheng-Shun Yang, Factors Associated with Quality of Life in Chronic Hepatitis C Patients Who Received Interferon Plus Ribavirin Therapy, Journal of the Formosan Medical Association, 2008, 107, 6, 454

    CrossRef

  126. 126
    Prem H. Thurairajah, Doha Hegazy, Shilpa Chokshi, Steve Shaw, Andrew Demaine, Edward R. Kaminski, Nikolai V. Naoumov, Matthew E. Cramp, Hepatitis C Virus (HCV)–Specific T Cell Responses in Injection Drug Users with Apparent Resistance to HCV Infection, The Journal of Infectious Diseases, 2008, 198, 12, 1749

    CrossRef

  127. 127
    Steeve Boulant, Mark W. Douglas, Laura Moody, Agata Budkowska, Paul Targett-Adams, John McLauchlan, Hepatitis C Virus Core Protein Induces Lipid Droplet Redistribution in a Microtubule- and Dynein-Dependent Manner, Traffic, 2008, 9, 8
    Direct Link:
  128. 128
    AA Modi, TJ Liang, Hepatitis C: a clinical review, Oral Diseases, 2008, 14, 1
    Direct Link:
  129. 129
    Baohong Zhang, M. A. Farwell, microRNAs: a new emerging class of players for disease diagnostics and gene therapy, Journal of Cellular and Molecular Medicine, 2008, 12, 1
    Direct Link:
  130. 130
    Catherine L. Jopling, Sylvia Schütz, Peter Sarnow, Position-Dependent Function for a Tandem MicroRNA miR-122-Binding Site Located in the Hepatitis C Virus RNA Genome, Cell Host & Microbe, 2008, 4, 1, 77

    CrossRef

  131. 131
    Gustine Liu-Young, Michael J. Kozal, Review:Hepatitis C Protease and Polymerase Inhibitors in Development, AIDS Patient Care and STDs, 2008, 22, 6, 449

    CrossRef

  132. 132
    Todd D. Bosse, Daniel P. Larson, Rolf Wagner, Doug K. Hutchinson, Todd W. Rockway, Warren M. Kati, Yaya Liu, Sherie Masse, Tim Middleton, Hongmei Mo, Debra Montgomery, Wen Jiang, Gennadiy Koev, Dale J. Kempf, Akhter Molla, Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors, Bioorganic & Medicinal Chemistry Letters, 2008, 18, 2, 568

    CrossRef

  133. 133
    F.-C. Tseng, B. R. Edlin, M. Zhang, A. Kral, M. P. Busch, B. A. Ortiz-Conde, T. M. Welzel, T. R. O’Brien, The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use, Journal of Viral Hepatitis, 2008, 15, 9
    Direct Link:
  134. 134
    R.S. Ross, S. Viazov, B. Wolters, M. Roggendorf, Towards a better resolution of hepatitis C virus variants: CLIPâ„¢ sequencing of an HCV core fragment and automated assignment of genotypes and subtypes, Journal of Virological Methods, 2008, 148, 1-2, 25

    CrossRef

  135. 135
    Anuradha Balasubramanian, Jerome E. Groopman, Ramesh K. Ganju, Underlying Pathophysiology of HCV Infection in HIV-Positive Drug Users, Journal of Addictive Diseases, 2008, 27, 2, 75

    CrossRef

  136. 136
    Manuela Torres-Puente, José M. Cuevas, Nuria Jiménez-Hernández, María Alma Bracho, Inmaculada García-Robles, Borys Wrobel, Fernando Carnicer, Juan del Olmo, Enrique Ortega, Andrés Moya, Fernando González-Candelas, Using evolutionary tools to refine the new hypervariable region 3 within the envelope 2 protein of hepatitis C virus, Infection, Genetics and Evolution, 2008, 8, 1, 74

    CrossRef

  137. 137
    Judith M. Gottwein, Jens Bukh, Advances in Virus Research Volume 71, 2008,

    CrossRef

  138. 138
    B. E. ANNICCHIARICO, M. SICILIANO, A. W. AVOLIO, R. L. GRILLO, G. BOMBARDIERI, A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy, Alimentary Pharmacology & Therapeutics, 2007, 25, 9
    Direct Link:
  139. 139
    Maria H. Sjogren, Robert Sjogren, Michael F. Lyons, Michael Ryan, John Santoro, Coleman Smith, K. Rajender Reddy, Herbert Bonkovsky, Brooke Huntley, Sima Faris-Young, Antiviral Response of HCV Genotype 1 to Consensus Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin, Digestive Diseases and Sciences, 2007, 52, 6, 1540

    CrossRef

  140. 140
    Jia Guo, Ran Yan, Guodong Xu, Weiyun Li, Congyi Zheng, Construction of the Vero cell culture system that can produce infectious HCV particles, Molecular Biology Reports, 2007, 36, 1, 111

    CrossRef

  141. 141
    Mauricio Lisker-Melman, Gregory S. Sayuk, Defining Optimal Therapeutic Outcomes in Chronic Hepatitis, Archives of Medical Research, 2007, 38, 6, 652

    CrossRef

  142. 142
    C. BROUARD, P. PRADAT, E. DELAROCQUE-ASTAGNEAU, C. SILVAIN, Epidemiological characteristics and medical follow-up of 61 patients with acute hepatitis C identified through the hepatitis C surveillance system in France, Epidemiology and Infection, 2007, 136, 07

    CrossRef

  143. 143
    Robert Rönn, Thomas Gossas, Yogesh A. Sabnis, Hanna Daoud, Eva Åkerblom, U. Helena Danielson, Anja Sandström, Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors, Bioorganic & Medicinal Chemistry, 2007, 15, 12, 4057

    CrossRef

  144. 144
    Panagiota Tsitoura, Urania Georgopoulou, Stéphane Pêtres, Agoritsa Varaklioti, Anastasia Karafoulidou, Dimitra Vagena, Constantina Politis, Penelope Mavromara, Evidence for cellular uptake of recombinant hepatitis C virus non-enveloped capsid-like particles, FEBS Letters, 2007, 581, 21, 4049

    CrossRef

  145. 145
    Niki Vassilaki, Haralabia Boleti, Penelope Mavromara, Expression studies of the core+1 protein of the hepatitis C virus 1a in mammalian cells, FEBS Journal, 2007, 274, 16
    Direct Link:
  146. 146
    Dorothea Sizmann, Claudia Boeck, Juergen Boelter, Daniela Fischer, Marion Miethke, Stefan Nicolaus, Markus Zadak, Reiner Babiel, Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS® AmpliPrep/COBAS® TaqMan® System, Journal of Clinical Virology, 2007, 38, 4, 326

    CrossRef

  147. 147
    Nikolaos Pyrsopoulos, Lennox Jeffers, Hepatitis C in African Americans, Journal of Clinical Gastroenterology, 2007, 41, 2, 185

    CrossRef

  148. 148
    Marija Zeremski, Andrew H Talal, Hepatitis C viral kinetics during treatment of hepatitis C virus/HIV coinfected patients, Current Opinion in HIV and AIDS, 2007, 2, 6, 489

    CrossRef

  149. 149
    Juan Cristina, María del Pilar Moreno, Gonzalo Moratorio, Hepatitis C virus genetic variability in patients undergoing antiviral therapy, Virus Research, 2007, 127, 2, 185

    CrossRef

  150. 150
    Juan Cristina, Hepatitis C virus: quasispecies dynamics, virus persistance and antiviral therapy, Expert Opinion on Therapeutic Patents, 2007, 17, 5, 499

    CrossRef

  151. 151
    Marc S. Itskowitz, Hepatitis C: Epidemiology, Diagnosis, and Management, Comprehensive Therapy, 2007, 33, 2, 87

    CrossRef

  152. 152
    Teresa I. Ng, Hongmei Mo, Tami Pilot-Matias, Yupeng He, Gennadiy Koev, Preethi Krishnan, Rubina Mondal, Ron Pithawalla, Wenping He, Tanya Dekhtyar, Jeremy Packer, Mark Schurdak, Akhteruzzaman Molla, Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology, Hepatology, 2007, 45, 6
    Direct Link:
  153. 153
    Yukari Takao, Akira Yamada, Shigeru Yutani, Hiroko Takedatsu, Takeharu Ono, Kojyu Etoh, Yi Wang, Susumu Suzuki, Tatsuya Ide, Kunitada Shimotohno, Michio Sata, Kyogo Itoh, Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b+ HLA-A24+ patients, Hepatology Research, 2007, 37, 3
    Direct Link:
  154. 154
    Koko Bate Aborsangaya, Iga Dembinski, Suresh Khatkar, Martin Prince Alphonse, Peter Nickerson, Julia D. Rempel, Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: Interaction with IL-10 gene polymorphisms, Hepatology, 2007, 45, 3
    Direct Link:
  155. 155
    Sanaa M. Kamal, Improving Outcome in Patients With Hepatitis C Virus Genotype 4, The American Journal of Gastroenterology, 2007, 102, 11, 2582

    CrossRef

  156. 156
    P. H. THURAIRAJAH, D. THORBURN, S. HUBSCHER, A. WHITE, W. K. LAI, K. O’DONNELL, D. MUTIMER, Incidence and characterization of serum transaminases elevations in pegylated interferon and ribavirin treated patients with chronic hepatitis C, Alimentary Pharmacology & Therapeutics, 2007, 25, 11
    Direct Link:
  157. 157
    Andrea De Maria, Manuela Fogli, Stefania Mazza, Monica Basso, Antonio Picciotto, Paola Costa, Sonia Congia, Maria Cristina Mingari, Lorenzo Moretta, Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients, European Journal of Immunology, 2007, 37, 2
    Direct Link:
  158. 158
    Shigeru Yutani, Akira Yamada, Kazumi Yoshida, Yukari Takao, Mayumi Tamura, Nobukazu Komatsu, Tatsuya Ide, Masatoshi Tanaka, Michio Sata, Kyogo Itoh, Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy, Vaccine, 2007, 25, 42, 7429

    CrossRef

  159. 159
    Vito Racanelli, Tobias Manigold, Presentation of HCV antigens to naive CD8+T cells: Why the where, when, what and how are important for virus control and infection outcome, Clinical Immunology, 2007, 124, 1, 5

    CrossRef

  160. 160
    H.M.Y. Mudawi, H.M. Smith, I.A. Fletcher, S.S. Fedail, Prevalence and common genotypes of HCV infection in Sudanese patients with hepatosplenic schistosomiasis, Journal of Medical Virology, 2007, 79, 9
    Direct Link:
  161. 161
    Hiroshi Murayama, Yoshihiro Fukuda, Shoji Tsunekawa, Masaki Ikemoto, Atsuo Nagata, Ratio of serum ornithine carbamoyltransferase to alanine aminotransferase as a potent indicator for hepatocellular carcinoma, Clinical Biochemistry, 2007, 40, 13-14, 1077

    CrossRef

  162. 162
    Rakesh L. Tripathi, Preethi Krishnan, Yupeng He, Tim Middleton, Tami Pilot-Matias, Chih-Ming Chen, Daryl T.Y. Lau, Stanley M. Lemon, Hongmei Mo, Warren Kati, Akhteruzzaman Molla, Replication efficiency of chimeric replicon containing NS5A–5B genes derived from HCV-infected patient sera, Antiviral Research, 2007, 73, 1, 40

    CrossRef

  163. 163
    Yukari Takao, Akira Yamada, Shigeru Yutani, Takeharu Ono, Yumiko Nagao, Eiji Ando, Tatsuya Ide, Kyogo Itoh, Michio Sata, Serum levels of IgG to the peptide of HCV1b core at positions 35–44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132–2140 correlated with better prognosis in HCV-infected patients, Medical Microbiology and Immunology, 2007, 196, 3, 157

    CrossRef

  164. 164
    Christoph Welsch, Mario Albrecht, Jochen Maydt, Eva Herrmann, Martin Walter Welker, Christoph Sarrazin, Axel Scheidig, Thomas Lengauer, Stefan Zeuzem, Structural and functional comparison of the non-structural protein 4B in flaviviridae, Journal of Molecular Graphics and Modelling, 2007, 26, 2, 546

    CrossRef

  165. 165
    Vinod K. Rustgi, The epidemiology of hepatitis C infection in the United States, Journal of Gastroenterology, 2007, 42, 7, 513

    CrossRef

  166. 166
    Sanaa M. Kamal, Khairy N. Moustafa, Jason Chen, Jutta Fehr, Azza Abdel Moneim, Khalifa E. Khalifa, Leila A. El Gohary, Amr H. Ramy, Mohamed A. Madwar, Jens Rasenack, Nezam H. Afdhal, Duration of peginterferon therapy in acute hepatitis C: A randomized trial, Hepatology, 2006, 43, 5
    Direct Link:
  167. 167
    Michèle Brocard, Sylvie Paulous, Anastassia V. Komarova, Vanessa Deveaux, Katherine M. Kean, Evidence that PTB does not stimulate HCV IRES-driven translation, Virus Genes, 2006, 35, 1, 5

    CrossRef

  168. 168
    Azuma Watanabe, Toshibumi Shimokawa, Mitsuhiko Moriyama, Fumihiko Komine, Shuichi Amaki, Yasuyuki Arakawa, Chisei Ra, Genetic variants of the IgA Fc receptor (FcαR, CD89) promoter in chronic hepatitis C patients, Immunogenetics, 2006, 58, 12, 937

    CrossRef

  169. 169
    Xavier Forns, Josep Costa, HCV virological assessment, Journal of Hepatology, 2006, 44, S35

    CrossRef

  170. 170
    Mostafa K. Mohamed, Iman Bakr, Mostafa El-Hoseiny, Naglaa Arafa, Abubakr Hassan, Soheir Ismail, Mohamed Anwar, Mohamed Attala, Claire Rekacewicz, Khaled Zalata, Mohamed Abdel-Hamid, Gamal Esmat, Arnaud Fontanet, HCV-related morbidity in a rural community of Egypt, Journal of Medical Virology, 2006, 78, 9
    Direct Link:
  171. 171
    Chuan-Mo Lee, Sheng-Nan Lu, Chao-Hung Hung, Wei-Chih Tung, Jing-Houng Wang, Hung-Da Tung, Chien-Hung Chen, Tsung-Hui Hu, Chi-Sin Changchien, Wei-Jen Chen, Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications, Transactions of the Royal Society of Tropical Medicine and Hygiene, 2006, 100, 8, 767

    CrossRef

  172. 172
    Andrew R Lloyd, Emma Jagger, Jeffrey J Post, Lee-Ann Crooks, William D Rawlinson, Young S Hahn, Rosemary A Ffrench, Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection, Immunology and Cell Biology, 2006, 85, 1, 24

    CrossRef

  173. 173
    Gundo Diedrich, How does hepatitis C virus enter cells?, FEBS Journal, 2006, 273, 17
    Direct Link:
  174. 174
    Christa Firbas, Bernd Jilma, Erich Tauber, Vera Buerger, Sandra Jelovcan, Karen Lingnau, Michael Buschle, Jürgen Frisch, Christoph S. Klade, Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects, Vaccine, 2006, 24, 20, 4343

    CrossRef

  175. 175
    Stanislas Pol, Vincent O Mallet, Improving anti-hepatitis C virus therapy, Expert Opinion on Biological Therapy, 2006, 6, 9, 923

    CrossRef

  176. 176
    Perdita Wietzke-Braun, Adil B. Maouzi, Larissa B. M??nhardt, Heike Bickeb??ller, Giuliano Ramadori, Sabine Mihm, Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection, European Journal of Gastroenterology & Hepatology, 2006, 18, 9, 991

    CrossRef

  177. 177
    Yoann Morice, Jean-François Cantaloube, Stéphanie Beaucourt, Laetitia Barbotte, Sija De Gendt, Fernando Lopes Goncales, Lesley Butterworth, Graham Cooksley, Robert G. Gish, Michel Beaugrand, Fabian Fay, Oscar Fay, Jorge E. Gonzalez, Regina Maria Bringel Martins, Daniel Dhumeaux, Bart Vanderborght, Lieven Stuyver, Erwin Sablon, Xavier de Lamballerie, Jean-Michel Pawlotsky, Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users, Journal of Medical Virology, 2006, 78, 10
    Direct Link:
  178. 178
    Heinz Zoller, Wolfgang Vogel, Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV ? focus on pegylated interferon-alpha, International Journal of Nanomedicine, 2006, 1, 4, 399

    CrossRef

  179. 179
    Sanaa M. Kamal, Amr E. Fouly, Refaat R. Kamel, Bridgette Hockenjos, Ahmed Al Tawil, Khalifa E. Khalifa, Qi He, Margaret J. Koziel, Khairy M. El Naggar, Jens Rasenack, Nezam H. Afdhal, Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response, Gastroenterology, 2006, 130, 3, 632

    CrossRef

  180. 180
    Jay H. Hoofnagle, Leonard B. Seeff, Peginterferon and Ribavirin for Chronic Hepatitis C, New England Journal of Medicine, 2006, 355, 23, 2444

    CrossRef

  181. 181
    Marija Mihailova, Melanie Fiedler, Mechthild Boos, Ivars Petrovskis, Irina Sominskaya, Michael Roggendorf, Sergei Viazov, Paul Pumpens, Preparation of hepatitis C virus structural and non-structural protein fragments and studies of their immunogenicity, Protein Expression and Purification, 2006, 50, 1, 43

    CrossRef

  182. 182
    Judith H. Aberle, Elisabeth Formann, Petra Steindl-Munda, Lukas Weseslindtner, Calin Gurguta, Gabriela Perstinger, Evelyn Grilnberger, Hermann Laferl, Hans P. Dienes, Theresia Popow-Kraupp, Peter Ferenci, Heidemarie Holzmann, Prospective study of viral clearance and CD4+ T-cell response in acute hepatitis C primary infection and reinfection, Journal of Clinical Virology, 2006, 36, 1, 24

    CrossRef

  183. 183
    Çetin Karaca, Yilmaz Çakaloğlu, Kadir Demir, Sadakat Özdil, Sabahattin Kaymakoğlu, Selim Badur, Atilla Ökten, Risk Factors for the Transmission of Hepatitis C Virus Infection in the Turkish Population, Digestive Diseases and Sciences, 2006, 51, 2, 365

    CrossRef

  184. 184
    Gamal Badra, Imam Waked, Carlo Selmi, Saleh M. Saleh, Ahmed El-Shaarawy, Mahmoud Lotfy, Serum Islet Cell Autoantibodies During Interferon α Treatment in Patients With HCV-Genotype 4 Chronic Hepatitis, Clinical and Developmental Immunology, 2006, 13, 1, 11

    CrossRef

  185. 185
    Daniel Yerly, Loriana Di Giammarino, Florian Bihl, Andreas Cerny, Targets of emerging therapies for viral hepatitis B and C, Expert Opinion on Therapeutic Targets, 2006, 10, 6, 833

    CrossRef

  186. 186
    Kyung-Soo Chang, Guangxiang Luo, The polypyrimidine tract-binding protein (PTB) is required for efficient replication of hepatitis C virus (HCV) RNA, Virus Research, 2006, 115, 1, 1

    CrossRef

  187. 187
    Myriam Vilasco, Esther Larrea, Damien Vitour, Stephanie Dabo, Adrien Breiman, Béatrice Regnault, Jose-Ignacio Riezu, Pierre Eid, Jesus Prieto, Eliane F. Meurs, The protein kinase IKKε can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers, Hepatology, 2006, 44, 6
    Direct Link:
  188. 188
    D Grimm, M A Kay, Therapeutic short hairpin RNA expression in the liver: viral targets and vectors, Gene Therapy, 2006, 13, 6, 563

    CrossRef

  189. 189
    John S. Bradley, Infectious Diseases of the Fetus and Newborn Infant, 2006,

    CrossRef

  190. 190
    Alessandro R. Zanetti, Elisabetta Tanzi, Augusto E. Semprini, Congenital and Other Related Infectious Diseases of the Newborn, 2006,

    CrossRef

  191. 191
    Brian W.J. Mahy, Emerging Viruses in Human Populations, 2006,

    CrossRef

  192. 192
    J.M. Bayas, M. Bruguera, Cómo combatir la transmisión nosocomial de la hepatitis C, Gastroenterología y Hepatología, 2005, 28, 8

    CrossRef

  193. 193
    Nikolaos Pyrsopoulos, Lennox Jeffers, Chronic Hepatitis C in African Americans, Clinics in Liver Disease, 2005, 9, 3, 427

    CrossRef

  194. 194
    Haizhen Zhu, David R. Nelson, James M. Crawford, Chen Liu, Defective Jak-Stat Activation in Hepatoma Cells Is Associated with Hepatitis C Viral IFN-α Resistance, Journal of Interferon & Cytokine Research, 2005, 25, 9, 528

    CrossRef

  195. 195
    Dimitrios Vassilopoulos, Leonard H Calabrese, Extrahepatic immunological complications of hepatitis C virus infection, AIDS, 2005, 19, Suppl 3, S123

    CrossRef

  196. 196
    Juan Cristina, Genetic diversity and evolution of hepatitis C virus in the Latin American region, Journal of Clinical Virology, 2005, 34, S1

    CrossRef

  197. 197
    R.M. Morillas, S. Montoliu, R. Planas, Hepatitis C, FMC - Formación Médica Continuada en Atención Primaria, 2005, 12, 2, 74

    CrossRef

  198. 198
    Peter W. M. Dienhart, Richard K. Sterling, Management of hepatitis C virus in patients with porphyria cutanea tarda, Current Hepatitis Reports, 2005, 4, 3, 104

    CrossRef

  199. 199
    David L. Thomas, Leonard B. Seeff, Natural History of Hepatitis C, Clinics in Liver Disease, 2005, 9, 3, 383

    CrossRef

  200. 200
    José L. Cital-Zamora, Rogelio Navarrete-Castro, Katya D. Magaña-Muñoz, Maria L. Martinez-Rodríguez, Gloria Maria Calderon, Prevalence of Hepatitis C Virus Genotypes in a Mexican Population, Archives of Medical Research, 2005, 36, 5, 607

    CrossRef

  201. 201
    Don C Des Jarlais, Theresa Perlis, Kamyar Arasteh, Lucia V Torian, Holly Hagan, Sara Beatrice, Lou Smith, Judith Wethers, Judith Milliken, Donna Mildvan, Stanley Yancovitz, Samuel R Friedman, Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001, AIDS, 2005, 19, Suppl 3, S20

    CrossRef

  202. 202
    Nigel Bourne, Richard B. Pyles, MinKyung Yi, Ronald L. Veselenak, Melissa M. Davis, Stanley M. Lemon, Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system, Antiviral Research, 2005, 67, 2, 76

    CrossRef

  203. 203
    Paul H. Hayashi, Adrian M. Di Bisceglie, The progression of hepatitis B– and C–infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis, Medical Clinics of North America, 2005, 89, 2, 371

    CrossRef

  204. 204
    Leonard H. Calabrese, Stanley J. Naides, Viral Arthritis, Infectious Disease Clinics of North America, 2005, 19, 4, 963

    CrossRef

  205. 205
    Ulrike Mihm, Eva Herrmann, Ulrike Sarrazin, Michael von Wagner, Bernd Kronenberger, Stefan Zeuzem, Christoph Sarrazin, Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C, Journal of Hepatology, 2004, 40, 5, 845

    CrossRef

  206. 206
    Jaquelyn Fleckenstein, Chronic hepatitis C in african americans and other minority groups, Current Gastroenterology Reports, 2004, 6, 1, 66

    CrossRef

  207. 207
    Doris B. Strader, Teresa Wright, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C, Hepatology, 2004, 39, 4
    Direct Link:
  208. 208
    Antonio Craxi, Early virologic response with pegylated interferons, Digestive and Liver Disease, 2004, 36, S340

    CrossRef

  209. 209
    William M. Lee, Jules L. Dienstag, Karen L. Lindsay, Anna S. Lok, Herbert L. Bonkovsky, Mitchell L. Shiffman, Gregory T. Everson, Adrian M. Di Bisceglie, Timothy R. Morgan, Marc G. Ghany, Chihiro Morishima, Elizabeth C. Wright, James E. Everhart, Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders, Controlled Clinical Trials, 2004, 25, 5, 472

    CrossRef

  210. 210
    Antonio Craxi, Foreword, Digestive and Liver Disease, 2004, 36, S333

    CrossRef

  211. 211
    John G McHutchison, Anouk T Dev, Future trends in managing hepatitis C, Gastroenterology Clinics of North America, 2004, 33, 1, 51

    CrossRef

  212. 212
    Mark W. Russo, Michael W. Fried, Guidelines for stopping therapy in chronic hepatitis C, Current Gastroenterology Reports, 2004, 6, 1, 17

    CrossRef

  213. 213
    Brian L. Pearlman, Hepatitis C Infection: A Clinical Review, Southern Medical Journal, 2004, 97, 4, 365

    CrossRef

  214. 214
    Nihat Akbayir, Gonca G??kdemir, T??lin Mansur, Mehmet S??kmen, Sevil G??nd??z, Canan Alkim, Burcu Barutcuoglu, Levent Erdem, Is There Any Relationship Between Hepatitis C Virus and Vitiligo?, Journal of Clinical Gastroenterology, 2004, 38, 9, 815

    CrossRef

  215. 215
    Volker Brass, Hubert E Blum, Darius Moradpour, Recent developments in target identification against hepatitis C virus, Expert Opinion on Therapeutic Targets, 2004, 8, 4, 295

    CrossRef

  216. 216
    W. Ray Kim, John J. Poterucha, Joanne T. Benson, Terry M. Therneau, The impact of competing risks on the observed rate of chronic hepatitis C progression, Gastroenterology, 2004, 127, 3, 749

    CrossRef

  217. 217
    Michelle M. Lipman, Scott J. Cotler, Antiviral therapy for hepatitis C, Current Treatment Options in Gastroenterology, 2003, 6, 6, 445

    CrossRef

  218. 218
    Victor E Buckwold, Brigitte E Beer, Ruben O Donis, Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents, Antiviral Research, 2003, 60, 1, 1

    CrossRef

  219. 219
    Patrick Marcellin, Nathalie Boyer, Chronic viral hepatitis, Best Practice & Research Clinical Gastroenterology, 2003, 17, 2, 259

    CrossRef

  220. 220
    Vito Racanelli, Barbara Rehermann, Hepatitis C virus infection: when silence is deception, Trends in Immunology, 2003, 24, 8, 456

    CrossRef

  221. 221
    Jean-Michel Pawlotsky, Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C, Antiviral Research, 2003, 59, 1, 1

    CrossRef

  222. 222
    Per Hoffmann, Maria Quasdorff, Maria Á González-Carmona, Wolfgang H Caselmann, Recent patents on experimental therapy for hepatitis C virus infection (1999 – 2002), Expert Opinion on Therapeutic Patents, 2003, 13, 11, 1707

    CrossRef

  223. 223
    Zobair M. Younossi, Kevin D. Mullen, Sandra Hodnick, David S. Barnes, William D. Carey, Arthur C. McCullough, Kirk Easley, Terry Gramlich, Belinda Yen Liebermann, Triple Combination of Interferon Alpha-2b, Ribavirin, and Amantadine for Treatment of Chronic Hepatitis C, Journal of Clinical Gastroenterology, 2003, 36, 5, 427

    CrossRef

  224. 224
    Peter Simmonds, David Mutimer, Hepatitis C Virus, Topley and Wilson's Microbiology and Microbial Infections,
    Direct Link:
Get PDF (1085K)